The Chinese Pharmaceutical Company Sinovac, announced the study of a new strain of the Coronavirus “Oomikron” and, if necessary, the preparedness of the start of development of the vaccine, writes the publishing “Penpii”.
It is reported that the company has a spent technology of vaccine production, as well as large production facilities. If necessary, the company can quickly launch the mass production of the vaccine to satisfy the demand.
Previously, Sinovac also worked on creating a vaccine from the strains of “Gamma” and “Delta”.